The Manufacturers Life Insurance Company Makes New $4.17 Million Investment in Crocs, Inc. $CROX

The Manufacturers Life Insurance Company purchased a new stake in Crocs, Inc. (NASDAQ:CROXFree Report) in the 2nd quarter, according to the company in its most recent Form 13F filing with the SEC. The firm purchased 34,600 shares of the textile maker’s stock, valued at approximately $4,174,000.

Other institutional investors have also modified their holdings of the company. BlackRock Inc. purchased a new stake in shares of Crocs during the second quarter worth $561,223,000. AQR Capital Management LLC boosted its holdings in Crocs by 399.0% in the third quarter. AQR Capital Management LLC now owns 1,266,799 shares of the textile maker’s stock valued at $105,841,000 after purchasing an additional 1,012,943 shares during the period. Patient Capital Management LLC purchased a new position in Crocs in the second quarter valued at $96,443,000. Norges Bank acquired a new position in Crocs during the 4th quarter worth $67,545,000. Finally, Himalaya Capital Management LLC acquired a new position in Crocs during the 4th quarter worth $53,720,000. Institutional investors and hedge funds own 93.44% of the company’s stock.

Crocs Stock Performance

NASDAQ:CROX opened at $115.28 on Wednesday. Crocs, Inc. has a 12 month low of $73.21 and a 12 month high of $141.28. The company has a debt-to-equity ratio of 0.94, a current ratio of 1.49 and a quick ratio of 0.96. The firm has a market capitalization of $5.53 billion, a PE ratio of 9.96, a price-to-earnings-growth ratio of 1.00 and a beta of 1.52. The business’s fifty day moving average price is $129.03 and its 200 day moving average price is $110.34.

Crocs (NASDAQ:CROXGet Free Report) last announced its quarterly earnings results on Thursday, July 30th. The textile maker reported $4.55 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $4.35 by $0.20. The company had revenue of $1.18 billion during the quarter, compared to the consensus estimate of $1.15 billion. Crocs had a return on equity of 47.75% and a net margin of 14.64%.Crocs’s revenue for the quarter was up 2.6% on a year-over-year basis. During the same period in the previous year, the business earned ($8.82) EPS. Crocs has set its FY 2026 guidance at 13.700-14.000 EPS and its Q3 2026 guidance at 3.200-3.300 EPS. On average, sell-side analysts anticipate that Crocs, Inc. will post 13.95 earnings per share for the current fiscal year.

Insider Buying and Selling at Crocs

In related news, CEO Andrew Rees sold 19,072 shares of the business’s stock in a transaction that occurred on Monday, August 10th. The stock was sold at an average price of $138.91, for a total transaction of $2,649,291.52. Following the completion of the sale, the chief executive officer owned 713,293 shares in the company, valued at $99,083,530.63. The trade was a 2.60% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through the SEC website. Over the last quarter, insiders sold 62,688 shares of company stock worth $8,014,859. 3.10% of the stock is currently owned by company insiders.

Wall Street Analyst Weigh In

CROX has been the topic of several recent research reports. Barclays upped their price target on Crocs from $110.00 to $118.00 and gave the stock an “equal weight” rating in a report on Friday, July 31st. Piper Sandler reissued an “overweight” rating on shares of Crocs in a research report on Friday, July 31st. Williams Trading set a $150.00 target price on shares of Crocs in a research note on Tuesday, June 9th. Stifel Nicolaus raised their target price on shares of Crocs from $105.00 to $125.00 and gave the company a “hold” rating in a report on Monday, June 15th. Finally, UBS Group raised their target price on shares of Crocs from $107.00 to $120.00 and gave the company a “neutral” rating in a report on Friday, July 31st. One analyst has rated the stock with a Strong Buy rating, ten have given a Buy rating, seven have given a Hold rating and two have issued a Sell rating to the company. According to data from MarketBeat.com, the stock currently has a consensus rating of “Moderate Buy” and an average target price of $139.10.

Check Out Our Latest Analysis on Crocs

About Crocs

(Free Report)

Crocs, Inc is a global footwear designer, developer and distributor best known for its lightweight, proprietary Croslite™ foam-clog construction. The company’s product portfolio encompasses a range of styles, including clogs, sandals, slides, boots and sneakers, all featuring the slip-resistant, odor-resistant and cushion-providing qualities of the Croslite material. Crocs distributes its products through an omnichannel network that includes e-commerce platforms, company-owned retail stores, authorized dealers and wholesale partners.

Founded in 2002 by Scott Seamans, Lyndon “Duke” Hanson and George Boedecker Jr., Crocs launched its first clog on the island of Vail, Colorado.

Further Reading

Want to see what other hedge funds are holding CROX? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Crocs, Inc. (NASDAQ:CROXFree Report).

Institutional Ownership by Quarter for Crocs (NASDAQ:CROX)

Receive News & Ratings for Crocs Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Crocs and related companies with MarketBeat.com's FREE daily email newsletter.